T1000	Negation 997 1000	not
E1000	Negation:T1000 Scope:T1001
T1001	Span 997 1035	not protect these cells from apoptosis
T1002	Negation 487 494	absence
E1001	Negation:T1002 Scope:T1003
T1003	Span 487 501	absence of EPO
T1004	Negation 1199 1202	not
E1002	Negation:T1004 Scope:T1005
T1005	Span 1199 1255	not sufficient to promote viability and/or proliferation
T1006	Negation 1103 1106	not
E1003	Negation:T1006 Scope:T1007
T1007	Span 1103 1129	not protect from apoptosis
T1008	Speculation 1307 1314	unknown
E1004	Speculation:T1008 Scope:T1009
T1009	Span 1307 1349	unknown pathway not including JAK2 or EPOR
T1010	Speculation 1143 1152	suggested
E1005	Speculation:T1010 Scope:T1011
T1011	Span 1143 1255	suggested that PKB/PI3-kinase activity is necessary but not sufficient to promote viability and/or proliferation
T1012	Speculation 1351 1354	may
E1006	Speculation:T1012 Scope:T1013
T1013	Span 1351 1515	may act in concert with the constitutive PI3-kinase/PKB/Akt pathway to protect the EPO-independent HCD57-SREI cells from apoptosis and promote limited proliferation
